Other NAP books related by word and phrase frequencies

The following titles are likely to be of interest to you. The top keyword and keyphrase weights from this report have been compared with the equivalent lists of words and phrases for all other available NAP publications.

• Building a National Framework for the Establishment of Regulatory Science for Drug Development:Workshop Summary (2011) (ISBN 0309158893) Yeonwoo Lebovitz, Rebecca English, and Anne Claiborne; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Prepositioning Antibiotics for Anthrax (2012) (ISBN 030921808X) Clare Stroud, Kristin Viswanathan, Tia Powell, and Robert R. Bass, Editors; Committee on Prepositioned Medical Countermeasures for the Public; Institute of Medicine


• Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development: Workshop Summary (2012) (ISBN 0309222141) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• Protecting the Frontline in Biodefense Research: The Special Immunizations Program (2011) (ISBN 0309209242) Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Select Agents; National Research Council


• The Future of Drug Safety: Promoting and Protecting the Health of the Public (2007) (ISBN 0309103045) Committee on the Assessment of the US Drug Safety System, Alina Baciu, Kathleen Stratton, Sheila P. Burke, Editors


• Challenges for the FDA: The Future of Drug Safety, Workshop Summary (2007) (ISBN 0309109868) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation


• Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (2012) (ISBN 0309261163) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine


• Ethical and Scientific Issues in Studying the Safety of Approved Drugs (2012) (ISBN 0309218136) Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs; Institute of Medicine


• Enhancing Food Safety:The Role of the Food and Drug Administration (2010) (ISBN 0309152739) Robert B. Wallace and Maria Oria, Editors; Committee on the Review of Food and Drug Administration's Role in Ensuring Safe Food; National Research Council


• The Public Health Emergency Medical Countermeasures Enterprise:Innovative Strategies to Enhance Products from Discovery Through Approval: Workshop Summary (2010) (ISBN 0309150248) Theresa Wizemann, Clare Stroud, and Bruce M. Altevogt, Rapporteurs; Forum on Medical and Public Health Preparedness for Catastrophic Events; Forum on Drug Discovery, Development, and Translation; Institute of Medicine


• A Risk-Characterization Framework for Decision-Making at the Food and Drug Administration (2011) (ISBN 0309212804) Committee on Ranking FDA Product Categories Based on Health Consequences, Phase II; National Research Council


• Food and Drug Administration Advisory Committees (1992) (ISBN 0309048370) Richard A. Rettig, Laurence E. Earley, and Richard A. Merrill, Editors; Committee to Study the Use of Advisory Committees, Institute of Medicine


• Understanding the Benefits and Risks of Pharmaceuticals: Workshop Summary (2007) (ISBN 0309107385) Forum on Drug Discovery, Development, and Translation, Leslie Pray, Rapporteur


• Ensuring Safe Foods and Medical Products Through Stronger Regulatory Systems Abroad (2012) (ISBN 030922408X) Jim E. Riviere and Gillian J. Buckley, Editors; Committee on Strengthening Core Elements of Regulatory Systems in Developing Countries; Board on Global Health; Board on Health Sciences Policy; Institute of Medicine


• Public Health Effectiveness of the FDA 510(k) Clearance Process: Balancing Patient Safety and Innovation: Workshop Report (2010) (ISBN 0309158494) Theresa Wizemann, Editor; Committee on the Public Health Effectiveness of the FDA 510(k) Clearance Process; Institute of Medicine